COVID-19: Caring for Patients and Communities
The Food and Drug Administration (FDA) warned last week that counterfeit at-home tests for COVID-19 are circulating within the United States.
Home health care (HHC) agencies' influenza vaccination policies are associated with reduced respiratory infection-related hospitalizations among older patients
The Joint Commission approved a new infection prevention and control standard and its elements of performance.
This week, the Food and Drug Administration issued an update ending emergency use authorization for sotrovimab
A U.K. study found no association between COVID-19 symptoms and the ability of infected people to infect to others.
Recent studies published by the JAMA Network shed light on risk factors for adverse birth outcomes.
In a March 28 letter, the American Hospital Association (AHA) asked the Department of Health and Human Services (HHS) to renew the COVID-19 public health emergency
Vaccination against COVID-19 appears to lower the risk of long COVID, according to a growing body of research.
Adults who received an initial Johnson & Johnson (J&J) COVID-19 vaccine should receive a Pfizer or Moderna booster at least two months later for the best protection
In a cohort study of 112,269 U.S. adult patients with moderate COVID-19, aspirin use during the first day of hospitalization was associated with lower 28-day in-hospital mortality